Drug company (FDA labeler)
Avyxa Pharma, LLC
NDC labeler code: 83831
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- CyclophosphamideFrindovyx · 6 products
- PemetrexedPemrydi Rtu, Alimta, Pemfexy · 4 products
- DocetaxelBeizray, Docivyx · 3 products
- Leucovorin calciumVykoura · 3 products
- GemcitabineAvgemsi, Inlexzo · 2 products
- CarboplatinKyxata · 2 products
- Bendamustine hydrochlorideTreanda, Vivimusta, Belrapzo · 2 products
- EtoposideVepesid, Avopef, Etopophos · 2 products
- FluorouracilFavlyxa, Tolak, Efudex · 2 products
- FulvestrantCligavyx, Faslodex · 1 product
- Palonosetron hydrochloridePosfrea · 1 product
- FosaprepitantFocinvez, Emend, Navitrux · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 24, 2026 | NDA220436 | Fosaprepitant NAVITRUX | Avyxa Holdings |
| February 20, 2026 | NDA220201 | Fluorouracil FAVLYXA | Avyxa Holdings |
| February 13, 2026 | NDA220200 | Etoposide AVOPEF | Avyxa Holdings |
| February 3, 2026 | NDA220406 | Leucovorin calcium VYKOURA | Avyxa Holdings |
| August 8, 2025 | NDA219921 | Carboplatin KYXATA | Avyxa Holdings |
| July 3, 2025 | NDA219014 | Bendamustine hydrochloride GOBARDEN | Avyxa Holdings |
| June 27, 2025 | NDA219920 | Gemcitabine AVGEMSI | Avyxa Holdings |
| June 28, 2024 | NDA210661 | Pemetrexed AXTLE | Avyxa Holdings |
| June 7, 2023 | NDA210852 | Cyclophosphamide FRINDOVYX | Avyxa Holdings |
| November 22, 2022 | NDA215813 | Docetaxel DOCETAXEL, DOCIVYX | Avyxa Holdings |
| August 19, 2019 | NDA210063 | Fulvestrant CLIGAVYX | Avyxa Holdings |
| March 1, 2016 | NDA203050 | Palonosetron hydrochloride POSFREA | Avyxa Holdings |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026